In race for tech supremacy, India can ill-afford to be mere spectator, says top Army officer
(You can now subscribe to our
(You can now subscribe to our Economic Times WhatsApp channel
The race for technological supremacy has begun, and India can ill-afford to be a mere spectator in it, Lt Gen Amardeep Singh Aujla , the Army's Master General Sustenance (MGS), said on Monday. He called on the defence industry to "march together" with the armed forces to create a secure future for the country.In his address at an 'Industry Interactive Session' hosted by the PHD Chamber of Commerce and Industry here, Lt Gen Aujla impressed upon the representatives of the domestic defence industry the importance of "customised solutions", as what is needed for Siachen will be different from the requirements for the armed forces in the plains or the desert."I am also looking at a capability that this industry should have. At the end of the day, even if we are in a conflict, you should be able to give me a solution based on my requirements within the earliest possible timeframe. So, that is the level of investment and R&D that has to happen," he said.The officer emphasised that if the end-user is the armed forces, quality should be the defining factor for the industry as "we are working for a national cause". He pointed out that it is "my moral duty to ensure that the soldier gets the very best".The industry and the armed forces can be "co-creators" of a very secure, robust and dynamic India of the future, Lt Gen Aujla said."Global dynamics are changing. India is also changing and so are the armed forces. When we are changing and we have got boots on the ground, we want equal boots on the ground and on the shop floor as well."So, let us not walk separately. Let us march together, let's be comrades in capability development," he told the gathering.In his address, the officer emphasised that India's military power, as far as the future is concerned, "will no longer get decided only in boardrooms and operation rooms.""It will now get decided also in R&D labs, on testing grounds and on the potency of the industry.""The race for technology or technological supremacy has begun and India can ill-afford to be a mere spectator... or just a participant. You (industry) are the people who will have to... take the charge and come up trumps," Lt Gen Aujla said. "So, it's a clarion call for everyone.""We have to rise, we have to step up, we have to deliver for the national cause. And in that national cause, revenue procurement and sustainability are extremely important," he added.Later, Lt Gen Aujla interacted with the audience and fielded a range of questions, including those on various policies of the Defence Ministry and some of the issues faced by private players in the defence sector.The Ministry of Defence has declared 2025 as the 'Year of Reforms'.Responding to a question on his expectations from these anticipated reforms, Lt Gen Aujla said he is "very, very optimistic".In his address earlier, the officer also said his proposition is that one "invests 40 per cent in the present, but looks at 60 per cent for the future"."We have to be ahead of the curve to give us solutions which not only enhance the combat effectiveness of the Indian Army but you should be looking at the global needs as well," he added."From being cost-effective to having capacities which are aligned with the needs of the nation, to quality that you produce, to the timeline that you adhere, to the competitiveness that has to come, whether it is cooperation versus competition or it is cooperation and competition, it is for you to take a call," Lt Gen Aujla said.The MGS of the Army said that as users "we are looking at our equipment and our sustainability in a matrix, which is absolutely top-notch". There is "no scope of any kind of dilution" whatsoever when it comes to quality, he underlined.Emphasising that "our biggest strength today has to be technology", he also pitched for hiking the quantum of investment in R&D. Through the industry, the Army is looking at digital transformation, effective use of AI, Machine Learning, blockchain, robotics, and enhancing cyber security, he said.He also said that unless the MSMEs and start-ups become strong and resilient, the Indian defence industry won't be able to make inroads in the desired manner.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
30 minutes ago
- Time of India
Trump rehashes years-old grievances on Russia investigation after new intelligence report
Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel President Donald Trump rehashed longstanding grievances over the Russia investigation that shadowed much of his first term, lashing out Tuesday following a new report from his intelligence director aimed at casting doubt on long-established findings about Moscow's interference in the 2016 election."It's time to go after people," Trump said from the Oval Office as he repeated a baseless claim that former President Barack Obama and other officials had engaged in was not making his claims for the first time, but he delivered them when administration officials are harnessing the machinery of the federal government to investigate the targets of Trump's derision, including key officials responsible for scrutinizing Russia's attempts to intervene on Trump's behalf in backward-looking inquiries are taking place even as the Republican administration's national security agencies are confronting global threats. But they have served as a rallying cry for Trump, who is trying to unify a political base at odds over the Jeffrey Epstein case, with some allies pressing to disclose more information despite the president's push to turn the attack prompted a rare response from Obama's post-presidential office."Our office does not normally dignify the constant nonsense and misinformation flowing out of this White House with a response," said Patrick Rodenbush, an Obama spokesman. "But these claims are outrageous enough to merit one. These bizarre allegations are ridiculous and a weak attempt at distraction."Gabbard's new report on the Russia investigation Trump's tirade, a detour from his official business as he hosted the leader of the Philippines, unfolded against the backdrop of a new report from Director of National Intelligence Tulsi Gabbard that represented his administration's latest attempt to rewrite the history of the Russia investigation, which has infuriated him for report, released Friday, downplayed the extent of Russian interference in the 2016 election by highlighting Obama administration emails showing officials had concluded before and after the presidential race that Moscow had not hacked state election systems to manipulate votes in Trump's Obama's Democratic administration never suggested otherwise, even as it exposed other means by which Russia interfered in the election, including through a massive hack-and-leak operation of Democratic emails by intelligence operatives working with WikiLeaks , as well as a covert influence campaign aimed at swaying public opinion and sowing discord through fake social media report appears to suggest the absence of manipulation of state election systems is a basis to call into question more general Russian interference. By issuing it, she appeared to recover her standing in Trump's orbit, which just one month ago had seemed uncertain after Trump said she was "wrong" when she previously said she believed Iran wasn't building a nuclear weapon."She's the hottest one in the room right now," Trump said Tuesday night. "Tulsi, great job - and I know you have a lot more coming."Democrats, for their part, swiftly decried the report as factually flawed and politically motivated."It is sadly not surprising that DNI Gabbard, who promised to depoliticize the intelligence community, is once again weaponizing her position to amplify the president's election conspiracy theories," Sen. Mark Warner, the top Democrat on the Senate Intelligence Committee , wrote on investigations found Russian interference in 2016 Russia's broad interference in 2016 has been established through a series of investigations, including special counsel Robert Mueller's report, which concluded that the Trump campaign welcomed the Kremlin's help but also found insufficient evidence to establish a criminal conspiracy.A House Intelligence Committee report also documented Russia's meddling, as did the Senate Intelligence Committee, which concluded its work in 2020 at a time when the panel was led by Republican Sen. Marco Rubio, who's now Trump's secretary of state.A different special counsel appointed by the Trump Justice Department to hunt for problems in the origins of the Russia investigation, John Durham, did find flaws, but not related to what Gabbard sought to highlight in her report."Few episodes in our nation's history have been investigated as thoroughly as the Intelligence Community's warning in 2016 that Russia was interfering in the election," said Rep. Jim Himes, the top Democrat on the House Intelligence added that every legitimate investigation, including the bipartisan Senate Intelligence Committee probe, "found no evidence of politicization and endorsed the findings" of an intelligence committee assessment on Russian interference made public in document was released weeks after a CIA report that reexamined that earlier intelligence community assessment. That new review, ordered by CIA Director John Ratcliffe, did not dispute Russia had interfered but suggested officials were rushed in the assessment they administration is seeking investigations of former officials Ratcliffe has since referred former CIA Director John Brennan to the Justice Department for investigation, a person familiar with the matter has said. The department earlier this month appeared to acknowledge an open investigation into Brennan and former FBI Director James Comey in an unusual statement, but the status and contours of the inquiries are Obama, Trump on Tuesday rattled off a list of people he accused of acting criminally "at the highest level," including Comey, his 2016 Democratic opponent Hillary Clinton and former national intelligence director James accused Obama, without evidence, of being the "ringleader" of a conspiracy to get him. Obama has never been accused of any wrongdoing as part of the Russia investigation, and, in any event, a landmark Supreme Court opinion from last year shields former presidents from prosecution for official acts conducted in launched his tirade when asked about the Justice Department's effort to speak with Ghislaine Maxwell, the former girlfriend of Epstein, who was convicted of helping the financier sexually abuse underage girls."I don't really follow that too much," he said. "It's sort of a witch hunt, a continuation of the witch hunt."Trump is under pressure from conspiracy-minded segments of his political base to release more about the Epstein case. Democrats say Trump is resisting because of his past association with Epstein. Trump has denied knowledge of or involvement with Epstein's crimes and said he ended their friendship years ago.
Time of India
an hour ago
- Time of India
200% tariffs in offing? Trump vows to slash drug prices using import restrictions
Older Americans most at risk Live Events Drug prices already higher than the rest of the world Experts warn Tariff plan could backfire Tariffs could push prices even higher Growing health debt adds to the pressure Rebuilding US drug production will take time (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel U.S. President Donald Trump announced on Tuesday his plan to use import restrictions as a tool to lower drug prices. He stated that foreign suppliers would be pressured to reduce their prices. Speaking at a White House event with Republican lawmakers, Trump addressed the issue of prescription drug costs. He pledged to decrease the amount consumers pay for these medications.'Drug companies will have lot of problems if they don't agree to bring prices down,' he said, making clear he plans to use trade policy as leverage. 'We are going to get drug prices down.' He also stated, 'We will use import restrictions to force foreign suppliers to cut drug prices.'Trump's latest proposal involves a 200 percent tariff on imported pharmaceuticals. His stated aim is to boost domestic drug manufacturing and reduce America's dependence on foreign supply first, he said the plan wouldn't take effect for another year. More recently, he hinted it could begin with a smaller tariff as early as 1 August and ramp up than 60 percent of adults in the US fill at least one prescription each year. That figure climbs sharply with age. According to the Centers for Disease Control and Prevention, nine out of ten Americans over 65 rely on prescription drugs to manage chronic health the high cost of medicine is already keeping many from getting the care they need. Research by the American Association of Retired Persons found that nearly half of adults aged 50 and older have either skipped a prescription because of cost or know someone who United States pays more for prescription drugs than any other country, according to the Department of Health and Human Services. One reason for this is the heavy reliance on imports. Many of the most-used medications in the US are manufactured have more than doubled over the past two decades. In 2006, pharmaceutical imports stood at $65 billion. By 2019, they had jumped to $151 billion. These drugs cover a wide range of treatments, including for arthritis, cancer, schizophrenia, blood clots, osteoporosis and Beschloss of RockCreek Group responded to Trump's proposal, saying, 'That would be potentially disastrous for every person because we need those pharmaceuticals, and it takes those companies a long time to produce them here in the U.S.'Analysts at UBS echoed that concern. They said even a 12-month delay in enforcing the 200 percent tariff offers 'insufficient time' for drug manufacturers to shift production to the US. A realistic timeframe, they believe, is closer to four to five Pharmaceutical Research and Manufacturers of America (PhRMA) commissioned research showing that a 25 percent tariff alone would raise US drug costs by nearly $51 billion. A 200 percent tariff would almost certainly cause even greater impact would be felt most in the generics market. Nearly 80 percent of generic tablets and capsules used in the US come from abroad. Brookings researchers warn that the narrow profit margins on generics mean even modest tariffs could push some drugs out of production altogether. For many patients, these are the only affordable debt in the US continues to rise. Americans collectively owe more than $220 billion in health-related expenses. Fourteen million people owe over $1,000 and three million owe more than $10, burden of higher drug prices will fall hardest on those who are already struggling. Older adults, disabled people and low-income families will likely bear the brunt of the production moved overseas gradually over several decades. Experts say bringing it back cannot be supporters of reshoring agree that the process needs to be managed carefully. A sudden shift could cause immediate drug shortages and price spikes, undermining the very goal of making medicines more accessible and broader aim of building a self-reliant drug supply is shared by many. But most agree the policy path to get there must avoid short-term shocks that could leave millions without the medicines they depend aggressive tariff proposal may play well politically, but the risk it carries for public health is difficult to ignore.
Economic Times
2 hours ago
- Economic Times
Gemini Horoscope Today, 22nd July 2025 - Trust The Slow Clarity
Synopsis Gemini Horoscope, 22nd July 2025: Geminis, you may have a lingering feeling that you're missing something or not moving fast enough, but that's okay. Trust this moment to quietly offer you growth in aspects of your life that truly need attention. Don't rush connections in love; allow feelings to evolve in their natural rhythm without forcing clarity. Your mind is fast and curious but your heart requires time to grow and understand the flow of life. Trust the learning process and focus on steady growth in your career. Avoid taking impulsive financial decisions and stay grounded while maintaining balanced health conditions. ET Online Gemini Horoscope Today, 22nd July 2025 - Trust The Slow Clarity Gemini Career Horoscope Today - 22nd July 2025Career situations may familiarise you with a subtle sense of confusion or incompleteness today. Trust your learning process, and remember that failures in work don't mean you're lagging behind. Try taking a small new approach or making gentle adjustments to bring different, better results instead of forcing a move. Don't compare your progress with others, everyone has a different path and a different journey. Stay focused on improving day by day and the right path will find Health Horoscope Today - 22nd July 2025Mental restlessness can cause slight unbalance today. To fix disturbed sleep or gather your thoughts that might feel scattered, try to avoid caffeine or sugary food late at night. Create a slow, peaceful routine for yourself and use the evening to recharge yourself. Don't be too avoidant of your body's signals, take short breaks and allow your thoughts to settle. Align your body and mind with patience. Gemini Love Horoscope Today - 22nd July 2025 Today might present uncertainties about where your connection is heading. Rushing and overthinking to expect immediate answers will lead you nowhere. In a relationship, avoid pushing your partner to explain everything, be patient and support your partner silently through words. Singles should take today's time to understand themselves first. Real love grows when you're calm inside. Gemini Money Horoscope Today - 22nd July 2025 Revisit your financial goals today and focus on what truly matters. Avoid borrowing, lending, or taking decisions under pressure today. Trust your planning and belief to yield results without letting temporary setbacks shake your steadily built thoughtful steps. Disclaimer Statement: This content is authored by a 3rd party. The views expressed here are that of the respective authors/ entities and do not represent the views of Economic Times (ET). ET does not guarantee, vouch for or endorse any of its contents nor is responsible for them in any manner whatsoever. Please take all steps necessary to ascertain that any information and content provided is correct, updated, and verified. ET hereby disclaims any and all warranties, express or implied, relating to the report and any content therein.
